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Abstract Gap junctions are key components underpin-
ning multicellularity. They provide cell to cell channel
pathways that enable direct intercellular communication
and cellular coordination in tissues and organs. The chan-
nels are constructed of a family of connexin (Cx) mem-
brane proteins. They oligomerize inside the cell, generating
hemichannels (connexons) composed of six subunits
arranged around a central channel. After transfer to the
plasma membrane, arrays of Cx hemichannels (CxHcs)
interact and couple with partners in neighboring attached
cells to generate gap junctions. Cx channels have been
studied using a range of technical approaches. Short pep-
tides corresponding to sequences in the extra- and intra-
cellular regions of Cxs were used first to generate epitope-
specific antibodies that helped studies on the organization
and functions of gap junctions. Subsequently, the peptides
themselves, especially Gap26 and -27, mimetic peptides
derived from each of the two extracellular loops of conn-
exin43 (Cx43), a widely distributed Cx, have been exten-
sively applied to block Cx channels and probe the biology
of cell communication. The development of a further series
of short peptides mimicking sequences in the intracellular
loop, especially the extremity of the intracellular carboxyl
tail of Cx43, followed. The primary inhibitory action of the
peptidomimetics occurs at CxHcs located at unapposed
regions of the cell’s plasma membrane, followed by inhi-
bition of cell coupling occurring across gap junctions.
CxHcs respond to a range of environmental conditions by
increasing their open probability. Peptidomimetics provide
a way to block the actions of CxHcs with some selectivity.
Furthermore, they are increasingly applied to address the
pathological consequences of a range of environmental
stresses that are thought to influence Cx channel operation.
Cx peptidomimetics show promise as candidates in
developing new therapeutic approaches for containing and
reversing damage inflicted on CxHcs, especially in hypoxia
and ischemia in the heart and in brain functions.
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Introduction
Gap junctions are cell–cell connections that ensure har-
monious integration, regulation and equalization of meta-
bolic events and signaling in tissues and organs. Their role
in the coordination of cell behavior is vividly illustrated in
the heart, where gap junctions in the intercalated discs
provide pathways that allow direct intercellular electrical
communication essential for synchronous contraction of
component myocytes and for generating waves of rhythmic
contractions observed in arteries. Gap junctions are con-
structed of paired connexin hemichannels (CxHcs), each
composed of six protein subunits arranged around a central
pore, and occur at adhesive areas where plasma membranes
Dedicated to the memory of Tudor Griffith, 1951–2011.
W. H. Evans (&)
Institute of Infection and Immunity, Cardiff University School
of Medicine, Heath Park, Cardiff, Wales CF14 4XN, UK
e-mail: EvansWH@cf.ac.uk
G. Bultynck
Department of Cellular and Molecular Medicine, K. U. Leuven
Campus Gasthuisberg, 3000 Leuven, Belgium
L. Leybaert
Department of Basic Medical Sciences, Physiology Group,
Faculty of Medicine and Health Science, Ghent University,
Ghent, Belgium
123
J Membrane Biol (2012) 245:437–449
DOI 10.1007/s00232-012-9488-5
touch. Hcs are continuously recruited from surrounding
unapposed plasma membrane areas and subsequently dock
head to head with partners from adjacent cells and attach to
the rims of preexisting gap junction plaques. The opera-
tional area and size of gap junction plaques where inter-
cellular communication occurs are regulated by a balanced
internalization and degradation of the dodecameric Cx
channel units (Laird 2006; Goodenough and Paul 2009).
Many approaches have been applied to study the struc-
ture and function of gap junctions and their constituent
CxHcs (Harris and Locke 2009). This account deals with
the development of peptides that correspond to specific
short Cx sequences that block widely the operation of gap
junctions and CxHcs. The consequences ensuing from the
actions of these peptides on Cx channels are allowing
research to move forward into the realms of translational
innovation across many fronts, especially in addressing the
pathological consequences of ischemic stress that induces
the channels to become leaky. Peptidomimetic approaches
are complemented by gene knockout and antisense siRNA
approaches to study Cx-based communication.
The development and application of short peptides
mimicking sequences in various protein domains of Cxs,
especially Cx43, initially focused on the two loops pro-
jecting outside the cell membrane; but peptides corre-
sponding to sequences in the cytoplasmic intracellular loop
and carboxyl tail are now finding application. Over the last
25 years, mimetic peptides have become important tools in
elucidating a panoply of roles for gap junctions and their
constituent CxHcs in a wide range of cells, tissues and
organs. These are summarized in Tables 1, 2 and 3.
Development and Exploitation of Cx Mimetic Peptides
Following the deduction of the complete amino acid
sequences especially of Cx32 and Cx43, two of the 20
members of the Cx family of proteins, a number of short
mimetic peptides were chemically synthesized and coupled
to immunogenic carriers to generate antibodies to target
specific domains and epitopes. The two highly conserved
extracellular loops of Cx have proven to be poorly
immunogenic, and it has been difficult to generate anti-
bodies to these domains. Nevertheless, antibodies to both
extracellular loop domains have been used in studies of a
wide range of functions underwritten by Cx channels.
These include (1) the topographical arrangement of Cx
proteins in the membrane (Zimmer et al. 1987), (2) the
roles of gap junctions in the development of mouse
embryos (Becker et al. 1995), (3) Ca2? wave signaling
across cell layers connected by gap junctions (Boitano
et al. 1998), (4) subcellular assembly of gap junctions
(Rahman et al. 1993), (5) coordination of Ca2? transients in
beating cardiac myocytes (Verma et al. 2009b), (6) Cx43 as
a candidate component of the immunological synapse
(Mendoza-Naranjo et al. 2011), (7) the functional impor-
tance of the two exposed extracellular loops (Goodenough
et al. 1988), (8) CxHc organization in polarized cells (Clair
et al. 2008) and (9) tracking conformational changes as Cx
traffic from the Golgi apparatus to gap junctions (Sosinsky
et al. 2007). Antibodies to peptides from intracellular
regions have been used extensively as diagnostic immu-
nological/analytical tools and are widely available from
commercial sources.
Although reagents such as heptanol, octanol, oleamide,
lithium ions, quinine derivatives, carbenoxolone, fena-
mates, anandamide, oleamide, triarylmethanes and glyc-
yrrhetinic acid inhibited gap junctional communication
(Herve and Dhein 2010; Juszczak and Swiergiel 2009;
Bodendiek and Raman 2010), there remained a need for
more specific reagents with a known mechanism of action.
From early on, it became evident that Cx mimetic peptides
used to generate the antibodies to gap junctions might
prove useful as chemical tools to manipulate channel
operation; it was argued that the utility of antibodies was
restricted by their size and limited penetration across the
cell membrane and into intercellular regions where gap
junctions are located. Such drawbacks would be overcome
by using small mimetic peptides that could penetrate into
intercellular junctions, disrupt the docking and/or operation
of hemichannels and, thus, target the gap junction (Fig. 1).
Two studies using model systems marked the beginning
of the exploration of Cx mimetic peptides as tools to study
gap junction functions. The first took advantage of the
contractile behavior displayed by embryonic chick heart
myoballs and known to require coordination provided by
intercellular communication via gap junctions. The effects
of a series of 15 Cx peptides, corresponding to short
sequences mainly in intra- and extramembrane amino acid
regions of the tetraspan membrane protein in delaying gap
junction functions, were determined (Warner et al. 1995). A
parallel study that used six dodecapeptide Cx mimetics to
interrupt communication across gap junctions generated in
Xenopus oocytes transfected with RNA to Cx32 (Dahl et al.
1994) likewise pointed to the potential of using short
peptides to tamper with Cx-dependent intercellular com-
munication. Warner et al. (1995) pinpointed motifs that
included short sequence motifs, SRPTEK in extracellular
loop 1 and SHVR in extracellular loop 2, as likely potent
peptides for use in disrupting cell communication. These
motifs were later incorporated into Gap26 and -27 mimetic
peptides and their close homologues (see Tables 1, 2, 3).
Kwak and Jongsma (1999) used dye coupling and dual
patch-clamp approaches to study the inhibition of Cx
channels using peptide mimetics from the second extra-
cellular loop of Cx43 and Cx40. An extensive literature has
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since built up around the study of Cx-dependent cell
communication processes, especially with peptides mim-
icking sequences in Cx43 and, to a lesser extent, Cx40 and
Cx37, which are widely expressed in the vascular system as
well as with Cx32 (De Bock et al. 2011). Gap26 and -27
have emerged as mimetic peptide tools that have entered
the literature in studies that explore the operation and
function of Cx channels in several settings (Tables 1, 2). As
discussed below, the blockage of direct cell coupling across
gap junctions (Evans and Boitano 2001) is now likely to be
a secondary event that follows initial interaction of the
peptides with CxHcs. Recent work is increasingly focused
on the translational and therapeutic possibilities offered by
the action of the mimetic peptides, especially in averting or
reversing tissue damage in ischemia and inflammation.
Gap Junctions and CxHcs
The view that CxHcs possess functions in their own right
and are able to operate in different modes from gap junc-
tions has now become generally accepted (Goodenough and
Paul 2003; Bennett et al. 2003; Evans et al. 2006). CxHcs
were detected in Xenopus oocytes (Ebihara and Steiner
1993), a test bed to study gap junction expression and
function and where the channels were observed to open in
low-Ca media. Hc opening was also detected in vertebrate
retinal dendrites (Malchow et al. 1993). These early studies
appeared against the background view that CxHcs sustained
in open configuration in membranes would lead to poten-
tially catastrophic cellular outcomes by allowing trans-
membrane escape from cells of small intracellular signaling
molecules, e.g., ATP and glutamate, and would result in a
collapse or dissipation of ionic gradients. The possible
importance of CxHcs operating under normal physiological
situations in cells and tissues was critically evaluated
(Spray et al. 2006). Collateral evidence for the functional
reality of CxHcs began to appear later for roles in pathology
with, e.g., the demonstration that leaky mutated CxHcs in
the ear were linked to deafness (Stong et al. 2006; Scott and
Kelsell 2011) and a mutation in the intracellular loop of
Cx43 that decreased single-channel conductance and is
linked to neurological disturbances in oculodentodigital
dysplasia (Lai et al. 2006). Reconstituted Hcs were used to
Table 1 Examples of the use of Gap26 and -27 mimetic peptides in studying the functions of gap junctions and connexin hemichannels in
tissues/organs, cell layers and slices
Test model Peptide Effects Reference
Arteries Gap26/27 Block rhythmic contractions Chaytor et al. (1997)
Mesenteric arteries Gap27 Attenuates hyperpolarization Dora et al. (1999)
Endothelium Gap27 Attenuates Ach relaxations Hutcheson et al. (1999)
Arteries Gap26/27 Block EHF signaling Chaytor et al. (2005)
Kidney Gap27 Blocks renal vasodilatation De Vriese et al. (2002)
Heart tissue Gap26 Aids recovery after hypoxia Hawat et al. (2010)
Heart lateral ventricle Gap27a Aids recovery after ischemia Davidson et al. (2012)
Arteries Gap27 Lowered intercell resistance Matchkov et al. (2006)
Lung capillaries Gap26/27 Inhibit Ca waves Parthasarathi et al. (2006)
Trophoblasts/fibroblasts Gap26/27 Block bilayer signaling and reduce DNA damage Bhabra et al. (2009)
Various cell barriers Gap27 Blocks signaling across barriers Sood et al. (2011)
Brain endothelial and MDCK
epithelial cells
Gap27 Inhibits Ca oscillations De Bock et al. (2012)
Leukocytes Gap27 Inhibits ATP release Eltzschig et al. (2006)
Hippocampus Gap27 Impairs learning, memory Bissiere et al. (2011)
Hippocampus slices Gap27 Inhibits epileptiform activity Samoilova et al. (2008)
Rat amygdala Gap27 Induces amnesia Stehberg et al. (2012)
Spinal cord Gap27a Reduces swelling, reduces neuronal cell death O’Carroll et al. (2008)
Optic nerve Gap27 Attenuates CNS injury Chew et al. (2010)
Hippocampus Gap27a Decreases cell death Yoon et al. (2010)
Lung Gap26 Reduces neutrophil transmigration Sarieddine et al. (2009)
Various cells Gap26 Blocks microtissue assembly Bao et al. (2011)
Skin model systems Gap27 Increased migration and proliferation Pollok et al. (2011)
Gap26, VCYDKSFPISHVR; Gap27, SRPTEKTIFI
a Gap27 analogue. See Table 2 for sequence. A Gap27 acting on Cx40 channels (SRPTEKNVFIV) has been used on vascular tissues where this
Cx is expressed
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investigate the influence of Ca and atomic force micros-
copy, to study Hc pore opening (Thimm et al. 2005). It is
now generally accepted that CxHcs open under environ-
mental circumstances considered to be stressful to cells
such as volume or osmotic changes; oxidative, metabolic
and mechanical stresses; and especially hypoxia/ischemia.
If not contained, leaky CxHcs can lead to apoptosis and
cell death (Saez et al. 2010; Decrock et al. 2009a, b).
Binding of mimetic peptides such as extracellular loop
peptides Gap26 and -27 to the extracellular face inhibited
functions associated with CxHcs; these are also regulated
by membrane depolarization, phosphorylation of several
sites on the carboxyl tail of Cx43 (Solan and Lampe 2009),
S-nitrosylation (Retamal et al. 2006) and SUMOylation of
lysine residues in the intracellular loop (Kjenseth et al.
2012). The particle–receptor hypothesis (see below)
explained the mechanics of gating in those Cxs with
extended cytoplasmic tails such as Cx43, Cx40 and Cx45
(Delmar et al. 2004). Recent evidence suggests that
mimetic peptide perturbation of intracellular domains,
especially the interactive cytoplasmic loop (CL) and the
carboxyl tail (CT), also influences Hc functions (Ponsaerts
et al. 2010). CxHc gating is also conditioned by signaling
cascades operating in subplasmalemmal environs (Fig. 2).
Besides structural differences, with Hcs being asym-
metrical and gap junctions being symmetrical double
channels, there are other important differences between the
functions of these weakly selective channels. CxHcs stand
out in being responsive to environmental changes and
contingencies. Gap junction channels allow the cytoplasms
of cells to be linked directly, whereas open CxHcs provide
channels connecting the cell’s external environment with
Table 2 Examples of use of Gap 26 and 27 mimetic peptides on various cells in culture
Test model/cells Peptide Effect References
Skin fibroblasts, keratinocytes Gap27 Increases migration in diabetes Wright et al. (2012a, b)
HeLa Cx43 GFP Gap26/27 Inhibit dye transfer Berman et al. (2002)
Lymphocytes Gap26/27 Inhibit transendothelial migration Oviedo-Orta et al. (2002)
T/dendritic cells Gap27 Cell sensitization abrogated Ring et al. (2010)
Mesenteric smooth muscle Gap27 Attenuates hyperpolerization Dora et al. (1999)
Alveolar epithelial Gap27 Inhibits Ca signaling Boitano and Evans (2000)
Alveolar epithelial Gap26/27 Inhibit dye transfer Isakson et al. (2003)
Neonatal myocytes Gap26 Inhibits ATP release in ischemia Clarke et al. (2009)
HeLa/cardiac cells Gap26/27 Inhibit Ca uptake and Ca waves Verma et al. (2009b)
CD4? T lymphocytes Gap27 Inhibits T-cell proliferation Oviedo-Orta et al. (2010)
B and T lymphocytes Gap26/27 Decrease antibody production Oviedo-Orta et al. (2010)
Corneal Gap26 ATP release and Ca waves blocked Gomes et al. (2005)
Ganglia Gap27a Limits retinal ganglion injury Danesh-Meyer et al. (2012)
Neural retinal Gap26 Limits ATP release and development Pearson et al. (2005)
Astrocytes Gap27 Abolished NMDA excitotoxicity Froger et al. (2010)
Astrocytes Gap26 Blocks glutamate release Jiang et al. (2011)
Astroglia Gap26/27 Block glutamate release Orellana et al. (2011)
Glioma Gap26/27 Delay apoptosis, cell death Decrock et al. (2009a, b)
Astroglia Gap26 Influences neural inflammation Karpuk et al. (2011)
Glia Gap26/27 Inhibit ATP release De Vuyst et al. (2009)
Astroglia Gap26 Inhibits ATP release and activation of P2Y receptors Orellana et al. (2012a)
Astrocytes Gap26/27 Induce anhedonia, depression Sun et al. (2012)
Blood–brain barrier endothelium Gap27 Inhibits ATP release and permeability of endothelium De Bock et al. (2011)
AT11 Gap27 Inhibits Ca waves Isakson et al. (2001)
Endothelium Gap26 Inhibits ATP release Robertson et al. (2010)
Bladder cancer Gap26/27 Inhibit ATP release De Vuyst et al. (2006)
T lymphocytes 1,848b Blocks GJ docking Mendoza-Naranjo et al. (2011)
Cardiomyocytes Gap26 Blocks CxHc in cardiac hypoxia Shintani-Ishida et al. (2007)
Platelets Gap27 Blocks Cx 43/37 channels Vaiyapuri et al. (2012)
Bone marrow stem cells Gap27 Confirms Cx channels absent Yang et al. (2009)
a VDCFLSRPTEKT peptide 5 derived from extracellular loop 2 of CxHc43
b Sequence of the Cx mimetic peptide not disclosed
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the cytoplasmic mileu beneath the plasma membrane. In a
cell-signaling context, changes in CxHc open probability
provide a mechanism for paracrine intercellular commu-
nication by allowing small molecules such as ATP and K to
exit and Ca to enter cells. ATP release underwrites puri-
nergic intercellular signaling (Isakson et al. 2001; Paem-
eleire et al. 2000; Kang et al. 2008), a function shared with
pannexin channels.
Gap junction channels exist normally in open mode, and
an elevation in intracellular Ca2? leads to closure (gener-
ally 500–2,000 nM). In contrast, CxHcs open at 500 nM
(De Vuyst et al. 2006, 2009, 2011). Differences in Ca
sensitivity of the two channel types may relate to their
complementary roles in regulating intracellular Ca oscil-
lations and the intercellular propagation of Ca waves
(Verma et al. 2009a; Orellana et al. 2012b; De Bock et al.
2012). The various intracellular processes that influence the
gating of Cx43Hcs are shown in Fig. 2b. Gap junctions and
CxHcs respond differently to lipopolysaccharide and basic
fibroblast growth factor, a consequence of their involve-
ment in releasing ATP (De Vuyst et al. 2007); their channel
functions also respond differently to many growth factors
(Schalper et al. 2012).
Widespread Use of Gap26 and Gap27 Mimetic Peptides
Cx43 is by far the most widely distributed Cx in tissues and
organs. It is therefore not surprising that Gap26 and -27,
derived from Cx43 sequences, have found extensive use. A
modified Gap27 peptide (Table 1) incorporating a
sequence mimicking that in Cx40 has also proven useful in
vascular tissues and other tissues where both Cxs are
present (Chaytor et al. 1999; Wright et al. 2009). Early
studies showed that inhibition by mimetic peptides was
largely reversible as assessed by intercellular transfer of
small fluorescent ‘‘reporter’’ dyes of varying size and by
Table 3 Effects of various intracellular Cx mimetic and other short and mainly Cx43 peptides on gap junctions and hemichannels
Test model Peptide Effect Reference
Brain synapses Carboxyl tail Prevents Cx36/GJ formation Flores et al. (2012)
Bladder cancer Gap24a Inhibits ATP release De Vuyst et al. (2006)
Mouse hearts Carboxyl tailb Increases Cx43 and ps368
phosphorylation
and induces arrhythmia
O’Quinn et al. (2011)
Heart Carboxyl tail May open gap junctions Lewandowski et al. (2008)
Heart R, any amino acid May open gap junctions Verma et al. (2009b)
Cardiac mitochondria Gap27 Inhibits Cx43 Rottlaender et al. (2012)
T lymphocytes Gap20c Ineffective on gap junctions Mendoza-Naranjo et al. (2011)
Endothelium- denuded arteries Gap20c Ineffective on gap junctions Chaytor et al. (1997)
C6 glioma cells L2 segment nonapeptide Blocks CxHc but not gap junctions Wang et al. (unpublished)
Corneal endothelial and C6 glioma
cells
TAT-L2 Blocks CxHc but not gap junctions Ponsaerts et al. (2010)
Basolateral amygdala Cx43-L2 TAT Blocks gliotransmitter release Stehberg et al. (2012)
MDCK CT9 peptideb Carboxyl
tail
Blocks Ca oscillations by removing
high Ca closure
De Bock et al. (2012)




Closure at ~ 3min
Cx43 Hemichannels
Cx43 junction channels
Closure at ~ 3min or longer
Fig. 1 Mechanism of action of Gap26 and -27 mimetic peptides.
Peptides bind to extracellular loop regions one and two, respectively,
of CxHc, causing closure of channels within minutes. At later time
intervals (30 min or longer) and depending on factors such as cell
confluency, tissue, organ, tissue slice origin and thickness and
conditions of perfusion of various organs, peptides permeate into
intercellular spaces in gap junctions, causing disruption and dimin-
ished cell coupling. CxHcs with attached peptide move laterally
toward the rims of gap junction plaques as they assemble and are then
internalized
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measuring the extent of Ca wave propagation over multiple
rows of cells (Boitano and Evans 2000).
As the operational presence of CxHcs became evident,
inhibition by mimetic peptides of ATP release in a wide
range of tissues and cells (Tables 1, 2), of glutamate in
astrocytes (Yang et al. 2009) and astrocytes/microglia
(Orellana et al. 2011) and of ion trafficking, especially Ca2?
entry, were observed. Uptake of reporter dyes across CxHcs
became a reliable and routine method to demonstrate open
or leaky CxHcs (Li et al. 1996). A range of other effects
were also noted on prolonged exposure (20 min or longer)
to the mimetic peptides such as smooth muscle contraction
in endothelium-denuded arteries (Chaytor et al. 1997;
Hutcheson et al. 1999) and immunoglobulin production by
lymphocytes (Oviedo-Orta et al. 2001). Subsequently, as
the presence of CxHcs widened, it became increasingly
clear that the primary action of Gap26 and -27 is in fact
directed at CxHcs. Nevertheless, a combination of direct
signaling across gap junctions and paracrine signaling act-
ing through metabotropic purinergic receptors following
release of ATP (Fig. 2) provides scope for complementary
intercellular interplay involving both routes in several set-
tings (Anselmi et al. 2008; Cotrina et al. 1998).
Initial experiments showing inhibition by mimetic pep-
tides of CxHcs were carried out mainly using cultured cells
(Table 2), followed by numerous examples in various tis-
sues and organs, cell layers and thin tissue slices (Table 1).
The growing attribution of nonjunctional properties to
CxHcs (Cotrina et al. 2008; Kameritsch et al. 2011) has led
to studies that attempt to unravel the potential functions in
the realms of adhesion and cell movement. Enhancement
of migration of dermal fibroblasts after treatment with
Gap27 pointed to nonjunctional roles for CxHcs in cell
movement and extending, e.g., to assessing their potential
translational application in addressing their efficacy in
accelerating wound healing in diabetes and in a range of
micro-/macrovascular diseases (Wright et al. 2009, 2012a;
Pollok et al. 2011). Gap27 increased migration of human
keratinocytes and dermal fibroblasts, and the efficacy of the
mimetic peptide was different in euglycemia and hyper-
glycemia (Wright et al. 2012b). Gene array approaches
indicated that Gap27 induced upregulation of genes
involved in extracellular matrix remodeling and cell
adhesion. Exposure of cells to Gap27 may have effects on
Cx43 phosphorylation, especially of serine 368; phos-
phorylation of this amino acid decreases Cx43 channel
activity (Solan and Lampe 2009) and is a key process in the
gating of Cx43 channels. Many of the effects of the
mimetic peptides were seen after long-term exposures.
Cx43 has been detected in the inner mitochondrial mem-
brane of heart cells and has been implicated in cardiac
preconditioning (Boengler et al. 2009; Rottlaender et al.
2012). The opening of mitochondrial CxHc influences K?
fluxes in processes that are linked to cardioprotection. The
functions of Cx43Hc at this location are open to study
using mimetic peptides developed to Cx43 cytoplasmic
sequences (Verma et al. 2009a).
Mechanism of Action of Cx Mimetics
To further develop and refine the actions of Cx mimetics, it
is important to gain insight into the mechanisms by which
they block Cx channels. A major advance was the dem-
onstration that the primary action of Gap26 and -27 was
likely to be on CxHcs prior to blockage of gap junctions.
With the acceptance that CxHcs and gap junctions were
targets but in different time frames, the effects of the
peptides on both were examined using electrophysiological
approaches. These had already proven useful in studying
Fig. 2 a Several intracellular signals and events influence CxHc
functions. Membrane depolarization above ?30 V opens Hc. Several
kinases may also be involved; PKC closes Hc, while p38MAPK and
calmodulin kinases result in Hc opening. The cytoplasmic Ca
concentration ([Ca2?]i) is also an important modulator; below
500 nM [Ca?] calmodulin is a key Ca binding protein and specific
binding sites are present on Cx. An increase in intracellular Ca causes
Hc opening, while Hc activation is lost at higher concentrations.
Arachidonic acid stimulates Hc opening, and amino acid metabolites
generated by PLA2 activation may contribute to this. Nitric oxide and
oxidative stress also result in opening of Hc. Figure modified from De
Vuyst et al. (2009). b a Sites on the exposed extramembrane regions
of Cx43 where the mimetic peptide sequences originated. b Proposed
intramolecular mechanism of CxHc gating involving interaction of
the carboxyl tail with the intracellular loop. c Binding of a
nonapeptide mimetic derived from L2, the Cx43 intracellular loop
region to a site on the carboxyl terminus regulates the closure of
CxHc and leads to blockage of the channel
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electrical coupling across gap junctions in cell pairs and the
electrical properties of CxHcs (Harris 2001; Contreras et al.
2003; Saez et al. 2005). Using a voltage-clamp approach in
nonconfluent and confluent HeLa cells expressing Cx43,
Gap26 inhibited macroscopic currents through CxHcs in
2–3 min. In contrast, electrical coupling in cell pairs was
delayed and completely inhibited after 30 min or more
(Desplantez et al. 2012), indicating direct action of Gap26
on an exposed extracellular loop, as previously suggested
by studies of CxHcs inserted into lipid bilayers (Liu et al.
2006). The extended time course of action on gap junc-
tional electrical coupling suggests that longer diffusion
pathways into plasma membrane junctional domains lead
ultimately to blockage of gap junctional coupling (Fig. 1).
The changes in conductance and voltage gating of CxHcs
by Gap26 suggested interaction of the peptide at a con-
sensus sequence in the first extracellular loop that may
contribute to the inner wall of the pore (Sosinsky and
Nicholson 2005), resulting in a decrease in channel diam-
eter in the extracellular vestibule. Desplantez et al. (2012)
also proposed that, of the two voltage gates controlling Hc,
the slow gate is the more likely to be influenced by the
binding of Gap26.
An expanded complementary study by Wang et al.
(unpublished) examined the mechanism of action of Gap26
and -27 in HeLa cells stably transfected with Cx43 and in
pig ventricular myocytes endogenously expressing Cx43
using a voltage-clamp approach. Both mimetic peptides
inhibited Cx43Hc unitary currents within minutes. An
important outcome of this study with cardiac translational
implications was that unitary current activity was promoted
by a moderate elevation of cytoplasmic Ca, an event
observed in cardiac arrhythmogenesis.
Gap26 and -27 have been used mainly to inhibit Cx43
channels, but actions on other Cx channels have also been
studied. For example, Wright et al. (2009) carried out an
extensive study of the effects of Gap26 and -27 on dye
coupling in cells expressing several human Cxs and found
that Gap27 had broader Cx specificity than Gap26. In some
situations where multiple Cxs are expressed, as in skin,
broad specificity can be an advantage.
The precise protein domains to which Gap26 and -27
mimetic peptides attach and any conformational changes
induced in Cx channels remain to be determined. Fluo-
rescently labeled Gap26 and -27 are poorly soluble; but
evidence points to attachment and retention at cell exteri-
ors, and problems of image resolution could not answer the
issue of whether attachment of a mimetic peptide ligand to
a ‘‘channel receptor’’ sequence can lead to peptide inter-
nalization (Evans, unpublished work). Voltage-clamp
approaches have been useful in deciphering the inhibitory
action of these peptides on Cx channels and go a long way
toward resolving questions concerning the specificity of
mimetic peptide inhibitory effects. Cx mimetics have been
claimed as effective inhibitors due to steric pore block
(Wang et al. 2007). Steric block may indeed occur, but
recent data indicate that it only occurs when peptides are
used in the range of 1 mM and above (Wang et al.
unpublished). The examples shown in Tables 1 and 2 used
mainly protein concentrations of 100–250 lM. In the vast
majority of these studies, investigators have used scram-
bled peptides or short peptides derived from regions
believed not to be directly involved in channel operation
(often internal sequences) as controls and, in each instance,
they pointed to a high sequence dependence of mimetic
peptide action in blocking gap junctional coupling and,
more recently, ATP release or dye entry across CxHcs.
Pannexins, of which three are identified compared to
around 22 in the Cx family of proteins, also form oligo-
meric channels with a similar tetraspan topographical
arrangement in the membrane to CxHcs. However, these
two protein families share no amino acid homology. Pan-
nexins, unlike Cxs, are posttranslationally glycosylated
(D’Hondt et al. 2009; Scemes et al. 2009) and are disin-
clined to dock with partner pannexins on neighboring cells.
It follows that they are not expected to generate gap
junction-like structures and, indeed, are found at higher
levels inside cells (D’Hondt et al. 2011). In contrast, a
recent report claims that they can form gap junctions and
act as Ca leak channels in the endoplasmic reticulum (Is-
hikawa et al. 2011). Pannexins are relatively unaffected by
changes in cytoplasmic Ca2? levels and, unlike Cx, are
calmodulin-insensitive. Pannexins are especially abundant
in neural tissues. The action of Gap26 and -27 on pannexin
channel currents has not yet been rigorously tested. It is
worth noting that high sequence diversity occurs in the
intracellular loop of Cx proteins; the carboxyl tail of larger
Cx proteins also varies in length, sequence and the extent
of posttranslational modification.
Small peptides generally have little structural organi-
zation but may assume some on binding to a target that
then becomes subject to conformational change. Studies of
the interaction of calmodulin with mimetic peptides from
the intracellular loop of Cx43 demonstrate a way forward
toward functionally dissecting this key region of Cxs
(Myllykoski et al. 2009). A calmodulin binding region in
Cx43 was located to amino acid residues 136–158 (Zhou
et al. 2007). Clearly, further knowledge of the structural
organization of Cx43Hc is awaited along the lines available
on CxHc26 (Maeda et al. 2009; Oshima et al. 2011).
Table 3 lists the growing number of mimetic peptides
derived from the CL and CT that act on CxHcs and gap
junctions. Many of these peptides are not able to cross
the plasma membrane. To gain access to their sites
of action, many of these mimetics need to be attached
first to ‘‘Trojan’’ cell-penetrating peptides that contain a
W. H. Evans et al.: Manipulating Cx Channels 443
123
membrane-translocation motif (Jarver and Langel 2006).
Intracellular loop mimetic peptides with a positive charge
due to several lysine residues stand out as candidates, for
they can, depending on length, gain access to intracellular
targets without need for attachment of a membrane-pene-
trating peptide or by microinjection, as discussed below.
Indeed, peptides of around 1 kDa or less may be able to
access the cytoplasm via open CxHcs.
Mimetics and Other Cx Peptides as Agents to Address
Pathology
In a cardiac context, blockage by Gap26 and -27 of gap
junctional coupling between myocytes negated their can-
didacy for use, especially in therapeutic approaches to
address cardiac arrhythmia, for the outcomes of peptide
treatment were likely to compound the pathology. Conse-
quently, studies in heart focused on nonmimetic hexapep-
tides shown to be prorhythmic, especially ZP123 derived
from AAp10 and later renamed rotigaptide (Hagen et al.
2009; Herve and Dhein 2010). This hexapeptide promoted
changes to Cx phosphorylation, increased gap junctional
coupling (Clarke et al. 2006) and showed promise in ani-
mal models, where it prevented ventricular tachycardia in
myocardial ischemia (Xing et al. 2003). However, fol-
lowing inconclusive clinical trials, rotigaptide was not
developed further. Cellular studies showed that despite its
prorhythmic action on gap junctions, ZP123 also led to the
opening of CxHcs, causing ATP release. In a cardiac
myocyte ischemia model, Gap26 blocked the release of
ATP, whereas ZP123 enhanced its release across Cx43Hc
(Clarke et al. 2009). Other antiarrhythmic peptides—such
as Gap134, a prorhythmic dipeptide—were also developed
(Hennan et al. 2009).
In the meantime, encouraging outcomes in addressing
ischemic cardiomyopathy using Gap26 have appeared.
These results can be explained by the direct action of this
mimetic peptide on CxHc rendered open under hypoxic/
ischemic conditions. Hawat et al. (2010) showed that fol-
lowing myocardial ischemic insult, Gap26 helped to confer
protection through its binding to and blockage of Cx43Hc.
Similar protection from hypoxic stress by these peptides
has also been reported. Vascular leak and retinal ganglion
cell death were reduced by application of a close homo-
logue of Gap27 in an atrial ischemia model where Cx43Hc
expression was increased (Danesh-Meyer et al. 2012). The
same group also reported that infusion of Gap27 in a large
animal model with cerebral injury delayed the onset of
ischemic injury and suggested that Gap27 homologue
peptides reduced inflammation. For example, mimetic
peptide treatment reduced the spread of damage after
traumatic spinal cord injury where Cx43Hc plays a critical
role (O’Carroll et al. 2008; Huang et al. 2012). Such studies
combine to show that Gap26 and -27 mimetic peptides
acting on CxHc-related functions, especially in situations
of tissue injury, show therapeutic potential. In brain, inhi-
bition of inflammation-induced activation of Cx43Hc in
astroglial cells was attenuated by treatment with Gap26 and
-27, suggesting that the channels play a critical role in
instigating neuronal death and pointing to a neuroprotec-
tive role for these mimetic peptides (Froger et al. 2010).
Interaction of the mimetic peptides with CxHcs is also
likely to modify intracellular signaling cascades in subpl-
asma membrane environments (Fig. 2a).
The action of Gap26 and -27 on CxHcs and later at gap
junctions encouraged the view that pathological outcomes
could be fine-tuned if mimetic peptides were to become
available that confined their blocking action on CxHcs
resident in the plasma membrane. Attention had already
focused on the intracellular loop region implicated in
explaining gap junction gating in cardiac cells and
involving intramolecular interaction of the carboxyl tail
region with the intracellular loop L2 region (a region in
Cx43 incorporating amino acids 119–144) and described as
the particle–receptor hypothesis (Delmar et al. 2004). The
role of the L2 domain as a key molecular determinant of
Cx43 function originated from the acidification-related
closure of gap junctions (Delmar et al. 2004), and the
particle-receptor hypothesis has been proposed to explain
Cx43 closure during acidification, with the CT moving as a
flexible gating particle that binds to the L2 site at the
intracellular vestibule and leading to closure of the gap
junction pore. Because of the similarity to the inactivation
of K? channels, this mechanism has also been called the
ball and chain model of gap junction closure. A 34-amino
acid nonmimetic peptide (RXP-E) and its derivatives were
developed to target the Cx43CT (Shibayama et al. 2006;
Lewandowski et al. 2008; Verma et al. 2009a). When
coupled to cell-penetrating peptides, these composite pep-
tides successfully restored gap junctional coupling and
impulse propagation in cultured neonatal rat ventricular
cardiomyocytes. Although the ability of L2 peptide to bind
to the Cx43CT region has been intensively studied, less is
known about how it is influenced by pH.
Loop–tail interactions also control Cx43Hc opening
(Ponsaerts et al. 2010). The interaction of a cytoplasmic
loop domain with the C-terminal region is an important
requisite for the opening of Cx43Hc in response to stimuli
such as lowering of extracellular Ca2? or increasing
intracellular Ca2?. In contrast, Cx43 gap junctions behave
in the opposite manner and are closed by intramolecular
loop–tail interactions (Delmar et al. 2004; Hirst-Jensen
et al. 2007). Interfering with loop–tail interactions can
inhibit the operation of Cx43Hc. One way to suppress
CxHc operation in response to high intracellular Ca2+ is to
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activate the actomyosin contractile system, a process that
appears to physically dislodge the CT from the CL region
(Ponsaerts et al. 2012). Importantly, the selective myo-
sin11-ATPase inhibitor blebbistatin restores Cx43Hc
activity when cells are exposed to high intracellular Ca
(Ponsaerts et al. 2012). The proteins involved in this
mechanism linking Cx43Hc and the actomyosin contractile
system have not been identified, but a likely target is the
CT region of Cx43Hc, for Cx43 lacking the CT is inactive.
Even in the absence of a functional actomyosin cytoskel-
eton, loop–tail interactions in Cx43Hc can be disrupted
using mimetic peptides from the L2 region, and coupling
the peptides to a TAT cell-penetrating sequence inhibits
CxHc opening. An important interactive target of L2-
region peptides is the last 10 amino acids of the carboxyl
tail (CT10). Direct binding between the L2 domain and
CT10 has been demonstrated by surface plasmon reso-
nance. Thus, TAT-L2 allows exploitation of the opposite
regulation of gap junctions and Cx43Hc and can provide a
route to selectively inhibit Cx43Hc while maintaining gap
junctional communication. The importance of the 10–
amino acid terminal carboxyl domain has been studied in
detail also using electrophysiological approaches in Xeno-
pus oocytes where the TAT-L2 and TAT-CT10 peptide
constructs have been crucial in analyzing and deciphering
intramolecular loop–tail interactions (Ponsaerts et al. 2010,
2012). These studies illustrate how mimetic peptide
approaches for selectively studying the physiological
functions of Cx43Hc can complement knockdown/knock-
out approaches in, e.g., processes leading to cell death
(Decrock et al. 2011) and in brain functions in the baso-
lateral amygdala, where Cx mimetic peptides such as
Gap27 demonstrate that Cx43Hc activities are implicated
in amnesia (Stehberg et al. 2012).
A short nonmimetic peptide (designated RXP-E) that
bound to the carboxyl tail of Cx43, derived from heart
lysates and studied in animal and cellular models, pre-
vented action potential block in the heart (Lewandowski
et al. 2008). A series of nonmimetic peptides with a motif
designated RXP and containing a predominance of basic
amino acid increased the mean open time of gap junc-
tion channels; these peptides were proposed as potential
functional regulators in ischemia-induced arrhythmias
(Shibayama et al. 2006; Verma et al. 2009a).
Currently, the application of novel short peptides mim-
icking sequences in the L2 region of Cx43 (Delmar et al.
2004) where a putative calmodulin binding site is identified
(Zhou et al. 2007) proceeds. One major aim is to design
mimetic peptides that confine their blocking actions to
CxHcs with no interference on gap junction functionality,
thus avoiding pro-arrhythmic consequences and allowing
the bound mimetic peptide to arrest, e.g., the loss of vital
cell metabolites via CxHcs in cardiomyocytes subject to
hypoxia or ischemia perfusion injury. A potential tool for
more selective inhibition of Hcs without associated inhi-
bition of gap junctions is a synthetic mimetic peptide
corresponding to the L2 region that, when delivered into
the cell by a whole-cell recording pipette, prevented gap
junctional opening to the subconductance state at high
transjunctional voltage and increased the channel open
time (Ponsaerts et al. 2010). Also, L2 peptide linked to the
TAT membrane translocation motif (TAT-L2) inhibited
Cx43Hc activation, further suggesting that prevention of
interaction of CT and CT suppresses Hc opening. Conse-
quently, the particle–receptor hypothesis described above
has an opposite outcome for Hcs compared to gap junc-
tions. This raises questions concerning why this is so, for
the composite proteins of the channels are identical but the
Ca sensitivity of the Cx43Hc and gap junctions differs. It
now appears that intracellular interactive partners may also
be different at the cytoplasmic aspects of junctional and
nonjunctional regions of the plasma membrane. One pos-
sible reason for these differences is that Hcs interact with
the actomyosin contractile system, causing dynamic loop–
tail interactions that control Hcs that differ from those
occurring at gap junctions (Ponsaerts et al. 2012).
New mimetic peptides derived from the carboxyl tail of
Cx43 are also being assessed. Here, peptide mimetic
design has to deal with a region where the CT interacts
with cytoskeletal elements (Herve et al. 2011; Palatinus
et al. 2011). This region also incorporates several phos-
phorylation sites that condition channel gating (Solan and
Lampe 2009). In the heart, the cytoskeletal adaptor protein
ankyrin-G interacts with Cx43 and is a likely key inter-
calated disc complex in the pathophysiology of arrhyth-
mias (Sato et al. 2011). A short Cx43-CT peptide
incorporating the last nine amino acids and linked to a cell
permeabilization sequence inhibited pathological changes
at gap junctions that are related to ventricular arrhythmias
(O’Quinn et al. 2011). This peptide disrupted the interac-
tion between the PDZ domain of ZO1 and Cx43, thus
accelerating assembly of gap junctions from a precursor
pool of Hcs (Hunter et al. 2005; Rhett and Gourdie 2012).
The peptide also enhanced PKC-epsilon-associated phos-
phorylation at the Cx43-S368 site, an effect that is acti-
vated in ischemic preconditioning and can reduce cardiac
injury (Ek-Vitorin and Burt 2012; Srisakuldee et al. 2009).
A similar peptide with the same sequence named CT9
prevented high Ca–induced closure of Cx43Hc (De Bock
et al. 2012; Ponsaerts et al. 2012). In the same vein, a
15–amino acid mimetic peptide derived from a sequence in
the CT of Cx36 modified gap junction conductance in
goldfish electrical synapses, and this peptide was injected
intradendritically (Flores et al. 2012).
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Concluding Comments
Peptides that mimic short sequences in extramembrane
domains of Cx proteins show huge potential in addressing
Cx-based communicationopathies by pharmacological
means. The functions attributed to Cx, especially Cx43,
continue to expand and include not only roles in intercellular
cell communication effected by CxHc and gap junctions but
also cell adhesion, cell migration and mitochondrial inner
membrane channel functions. It is likely that the range of Cx
mimetics and their applications will increase, for they pro-
vide activation mechanisms for manipulation of intercellular
signaling and communication. Furthermore, the peptides can
also help cells protect themselves from events emanating
from leaky channels, events that may ultimately lead to
apoptosis. Intriguingly, in the brain the Gap26 and -27
mimetic peptides that act mainly on astrocyte Cx channels
have been shown to affect depression (anhedonia), epilep-
tiform activity, memory consolidation and amnesia, further
emphasizing the importance of Cx-mediated communication
and signaling in a wide range of settings.
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